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Summary
The establishment of neural circuitry requires vast
numbers of synapses to be generated during a spe-
cific window of brain development, but it is not known
why the developing mammalian brain has a much
greater capacity to generate new synapses than the
adult brain. Here we report that immature but not ma-
ture astrocytes express thrombospondins (TSPs)-1
and -2 and that these TSPs promote CNS synaptogen-
esis in vitro and in vivo. TSPs induce ultrastructurally
normal synapses that are presynaptically active but
postsynaptically silent and work in concert with other,
as yet unidentified, astrocyte-derived signals to pro-
duce functional synapses. These studies identify TSPs
as CNS synaptogenic proteins, provide evidence that
astrocytes are important contributors to synaptogen-
esis within the developing CNS, and suggest that
TSP-1 and -2 act as a permissive switch that times
CNS synaptogenesis by enabling neuronal molecules
to assemble into synapses within a specific window
of CNS development.
Introduction
Is synaptogenesis controlled solely by the pre- and
postsynaptic neurons, or are there pivotal nonneuronal
determinants that help to control the timing, location,
and number of synapses that form? We have been in-
vestigating the role of astrocytes, which ensheathe syn-*Correspondence: ksc@stanford.edu
6 These authors contributed equally to this work.
7 Present address: Departments of Ophthalmology and Physiology,
University of California, San Francisco, California, 94143, USAapses throughout the CNS, in controlling synaptogen-
esis. In previous studies, we found that, when purified
rat retinal ganglion cells (RGCs) are cultured in defined
serum-free conditions that fully support their survival
and growth, they form few synapses unless cultured
with astrocytes, as measured by electrophysiology,
FM1-43 imaging, immunostaining, and electron micro-
scopy (Mauch et al., 2001; Nagler et al., 2001; Pfrieger
and Barres, 1997; Ullian et al., 2004a). Similarly, purified
spinal motor neurons form few synapses unless cul-
tured with Schwann cells or astrocytes (Ullian et al.,
2004c). Culturing RGCs under feeding layers of astro-
cytes, without direct contact, is sufficient to enhance
synapse number, indicating that these effects are medi-
ated by one or more soluble signals secreted by astro-
cytes (Nagler et al., 2001; Pfrieger and Barres, 1997;
Ullian et al., 2001). The astrocyte-induced increase in
synapse number is not due to the absence of the nor-
mal target of these neurons because the same increase
in RGC synapse number and function is induced be-
tween RGCs and their normal target neurons purified
from the superior colliculus (Ullian et al., 2001).
What is the identity of these astrocyte-secreted sig-
nals? Here we identify thrombospondin family mem-
bers (TSPs) as necessary and sufficient synaptogenic
components of astrocyte-conditioned medium (ACM).
TSPs are large oligomeric extracellular matrix proteins
that mediate cell-cell and cell-matrix interactions by
binding an array of membrane receptors, other extra-
cellular matrix proteins, and cytokines (Adams, 2001;
Adams and Tucker, 2000; Bornstein, 2001; Lawler,
2000). There are five TSPs, each encoded by a separate
gene. Although several TSPs are expressed in the
brain, the functions of these TSPs are unknown (Adams
and Tucker, 2000; Iruela-Arispe et al., 1993; Scott-Drew
and ffrench-Constant, 1997). TSP1 and TSP2 are
closely related trimeric proteins that share the same set
of structural and functional domains. TSP4, which is
pentameric and has a different domain structure from
TSP1 and TSP2, is present in the adult nervous system
where it is localized to some CNS synapses as well as
the neuromuscular junction (Arber and Caroni, 1995).
The findings we report here identify TSPs as astrocyte-
secreted proteins that promote the formation of ultra-
structurally normal CNS synapses and reveal that addi-
tional, as yet unidentified, astrocyte-derived signals
control postsynaptic function.
Results
Astrocytes Secrete Two Activities that Affect
Synapse Formation and Function Differentially
In order to establish an assay for biochemical studies
to identify synaptogenic activities secreted by astro-
cytes, we compared the ability of astrocyte-condi-
tioned medium (ACM) and astrocyte feeding layers
(“Astros”) to induce synapses on RGCs (Figure 1A).
Synapses were detected as yellow puncta, represent-
ing colocalization of immunoreactivity to the pre- and
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422Figure 1. TSP1 Mimics the Synapse-Promoting Activity of ACM
(A) Immunostaining of RGCs for colocalization of presynaptic synaptotagmin (red) and postsynaptic PSD-95 (green) shows few synaptic
puncta in the absence of astrocytes (Control) but many in the presence of astrocyte-conditioned medium (ACM) or a feeding layer of
astrocytes (Astros), indicating that astrocytes secrete a synapse-promoting activity that is also active in ACM.
(B) Astrocyte feeding layer (Astros) increases frequency of spontaneous mEPSCs above control, while ACM does not.
(C) Synapse-promoting activity in ACM is over 100 kDa. ACM was concentrated with molecular weight cutoff (MWCO) filters of 5, 50, and 100
kDa. The number of puncta from ACM prepared with a 100 kDa MWCO filter is similar to the number of puncta produced by astrocyte feeding
layer, indicating that the astrocyte-derived synapse-promoting activity is over 100 kDa.
(D) Immunostaining for colocalization of presynaptic synaptotagmin (red) and postsynaptic PSD-95 (green) shows few RGC synaptic puncta
in the absence of astrocytes (Control) but many in the presence of 5 g/ml thrombospondin 1 (TSP1), indicating that TSP1 is sufficient to
increase synaptic puncta on neurons. Cholesterol induces no increase in puncta.
(E) Quantification of the effects of ACM, TSP1, and ACM + TSP1 on synaptic puncta. ACM and TSP1 significantly increase the number of
synaptic puncta over control. ACM + TSP1 increases synaptic puncta to the same extent as either ACM or TSP1 alone, indicating that the
effect of ACM is not additive with the effect of TSP1.
(F) Cholesterol (10 g/ml) does not increase the number of synaptic puncta in neurons. Asterisks in all panels correspond to p < 0.05
compared to control. Error bars are the mean ± SEM. Scale bars are 30 m.
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423postsynaptic markers synaptotagmin and PSD-95,
respectively. Each yellow punctum corresponds to the
site of a single functional synapse (Ullian et al., 2001).
As previously described (Ullian et al., 2001), RGCs cul-
tured for several days below a feeding layer of astro-
cytes have 7-fold more functional synapses than RGCs
cultured alone, as assayed by whole-cell patch record-
ing (Figure 1B). When RGCs were cultured in ACM,
there was an increase in the number of structural syn-
apses, indicated by an increase in both the number and
colocalization of pre- and postsynaptic puncta in the
presence of ACM (Figure 1A); however, these synapses
were not functional, as indicated by the frequency of
synaptic currents (Figure 1B). Despite this lack of func-
tion, quantification of immunostaining showed that
ACM induced as many structural synapses as an
astrocyte feeding layer (Figure 1C). This suggests that
there are at least two signals secreted by astrocytes:
one that is present in ACM that increases the number
of structural synapses and a second signal either not
produced in the absence of RGCs or lost during prepa-
ration of ACM (data not shown) that induces function-
ality.
TSP1 Is Sufficient to Mimic the ACM-Induced
Increase in Synapse Number
Having established an assay in which ACM exhibits the
same ability to induce synaptic puncta as an astrocyte
feeding layer, we next investigated the molecular
weight of the synaptogenic ACM component. We found
that all of the synapse-promoting activity in ACM was
larger than 100 kDa (Figure 1C), and the majority of the
activity was still retained with a 300 kDa cutoff filter
(data not shown). To test whether ApoE-containing par-
ticles could be responsible for the activity as previously
reported (Mauch et al., 2001), we immunodepleted
ApoE-containing complexes from ACM. Despite deple-
tion of virtually all of the ApoE protein, ACM induced
the same number of synapses (see Supplemental Fig-
ure S1 in the Supplemental Data available with this arti-
cle online). In addition, we found that treatment of
RGCs with either ApoE (data not shown) or cholesterol
(Figures 1D and 1F) had no effect on synapse number.
Therefore, ApoE bound cholesterol is not responsible
for the synapse-promoting activity of ACM. However,
cholesterol does strongly enhance synaptic efficacy, as
previously reported (Mauch et al., 2001; Supplemental
Figure S1).
The large size of the synaptogenic ACM activity, to-
gether with our unpublished observation that the activ-
ity is heparin binding (data not shown), strongly sug-
gested the possibility that the activity is an extracellular
matrix protein. We investigated the possibility that TSPs
contribute to the synaptogenic activity of ACM because
TSPs form large >500 kDa oligomeric complexes, are
made by astrocytes in vitro and in vivo (Adams and
Tucker, 2000; Iruela-Arispe et al., 1993; Scott-Drew and
ffrench-Constant, 1997), and are well established as regu-
lators of cell attachment in nonneural cells, and at least
one family member is localized to the neuromuscular
junction and to some synapses within the CNS (Arber
and Caroni, 1995). Purified TSP1 from human platelets
increased the number of synaptic puncta in RGCs to asimilar degree as ACM (Figures 1D and 1E). The number
of puncta per RGC induced by TSP1 increased in a
dose-dependent manner with concentrations of TSP1
ranging from 2 to 20 nM; 10 nM was the plateau con-
centration and was used in all subsequent experiments
(data not shown). We found no difference in the average
radii or the distance between the centers of colocalized
puncta between conditions (Supplemental Table S1),
indicating that the increase in synapse number was not
simply due to an increase in the size of the few synaptic
puncta present in control conditions. TSP1-induced
synaptic puncta exhibited immunoreactivity for a large
variety of presynaptic proteins including synaptotag-
min, synapsin, and Bassoon as well as postsynaptic
proteins including PSD-95, SAP102, and Homer (Sup-
plemental Figure S6). To determine whether the increase
in synapse number by TSP1 involved increased levels
of synaptic proteins, we measured protein levels in
control RGCs and RGCs treated with TSP1. Similar to
our previous results with astrocytes (Ullian et al., 2001),
we found that RGCs treated with TSP1 did not have
significantly increased levels of synaptic proteins com-
pared to control cultures (Supplemental Figure S2), in-
dicating that TSP is affecting synaptic protein localiza-
tion. In addition, the increase in synapses seen with
TSP1 treatment was not due to an increase in axon
length (DeFreitas et al. [1995], Neugebauer et al. [1991];
axon length 1 day in culture control, 196 ± 15 m; TSP1,
223 ± 18 m; means ± SD, n = 30; p > 0.05), dendrite
length, or altered process morphology (Supplemental
Figure S3).
To determine whether the synaptogenic effect was
specific to TSP1, we tested a panel of extracellular matrix
molecules known to be secreted by astrocytes (including
fibronectin, vitronectin, tenascin C, osteonectin/SPARC,
osteopontin, chondroitin sulfate proteoglycans A and
C, biglycan, decorin, and agrin) as well as battery of
peptide trophic factors (including TNFα, Il-6, GDNF,
bFGF, TGFβ1, HGF, and pleiotrophin). None of these
molecules had a significant effect on synapse number
(Supplemental Figure S3). In addition, BDNF, CNTF, and
insulin are present in our medium even in control condi-
tions where few synapses form.
ACM and TSP1-Induced Synapses
Are Ultrastructurally Normal
Are the ACM- and TSP1-induced synapses ultrastruc-
turally normal? We used electron microscopy to study
ACM- and TSP1-induced synapses in fine detail. Syn-
apses induced by TSP1 and ACM were ultrastructurally
identical to the electrophysiologically active synapses
induced by a feeding layer of astrocytes. Pre- and post-
synaptic specializations could be easily detected in
RGCs cultured under both conditions as well as with
an astrocyte feeding layer (Figure 2A). There was no
difference in the length or thickness of the postsynaptic
density (PSD) between synapses induced by TSP1 or
an astrocyte feeding layer (PSD length, 380 ± 197 nm
[TSP] versus 398 ± 209 nm [Astro, p = 0.8]; PSD thick-
ness, 46 ± 5 nm [TSP] versus 50 ± 8 nm [Astro, p = 0.7]).
The number of vesicles per synapse and the number
of docked vesicles per synapse were not statistically
different between these three conditions (Figure 2B),
Cell
424Figure 2. TSP1 Induces Ultrastructurally Normal Synapses
(A) Electron micrographs (EM) of synapses in the presence of ACM, TSP1, or astrocyte feeding layer (Astros). In all cases, ultrastructurally
normal synapses are seen.
(B) Quantification of total number of vesicles (black bars) and number of docked vesicles (gray bars) per synapse per section indicates no
difference between synapses formed in the presence of ACM, TSP1, or astrocytes, indicating that all three promote formation of normal and
indistinguishable ultrastructural synapses.
(C) Quantification of the number of synapses per cell per section measured by EM shows a significant increase in the number of synapses
on neurons cultured with ACM, TSP1, or astrocytes compared to control. Asterisks correspond to p < 0.05 compared to control. Error bars
are the mean ± SEM. Scale bar is 500 nm.and the increase in synapse number in all cases was i
gcomparable to our immunostaining results (Figure 2C).
cThese findings demonstrate that TSP1 is sufficient to
pinduce ultrastructurally normal synapses and provide
Tevidence that the synaptic structures we detect by
pimmunostaining likely correspond to the fully devel-
toped synaptic structures we observe by EM.
w
TSP2 Is a Necessary Component of the Synapse- W
Promoting Activity of ACM t
Which TSPs are expressed by cultured astrocytes? Of t
the five members of the TSP family, TSP1 and -2 are 1
highly related and share common functional domains, p
while TSP -3, -4, and -5/COMP lack some of the do- i
mains present in TSP1/2 (Adams, 2001). RT-PCR analy- a
sis of mRNA isolated from astrocytes in culture indi- A
cated expression of both TSP1 and TSP2 (data not c
shown). However, we were only able to detect protein o
for TSP2 by Western blotting of ACM and astrocyte cell e
lysate with TSP1- and TSP2-specific antibodies (data p
not shown and Figure 3C), even though the TSP1 anti- t
body recognizes rat TSP1 in serum (data not shown) s
and rat brain lysate (Figure 5E). a
Is TSP2 synaptogenic? We found that recombinant T
TSP2 (rTSP2) increased synapse number in RGCs to a a
similar degree as TSP1 (Figures 3A and 3B). This findingndicates that TSP1 and TSP2 both promote synapto-
enesis. In addition, the synaptogenic activity of re-
ombinant TSP2 provides evidence that the activity in
urified platelet TSP1 is not due to copurification of a
SP binding protein. This conclusion is further sup-
orted by the lack of visible contaminating proteins in
he recombinant TSP2 used for these experiments
hen analyzed by Coomassie staining.
Is TSP2 a necessary component of the ACM activity?
hen we treated RGCs with ACM and TSP1 together,
he increase in synapse number was not larger than
hat observed with treatment by either alone (Figure
E), suggesting that ACM and TSP1 share a common
athway. To test directly whether TSP2 is necessary, we
mmunodepleted TSP2 from ACM with a TSP2-specific
ntibody (Figure 3C). RGCs cultured in TSP2-depleted
CM developed several-fold fewer synaptic puncta
ompared to nondepleted ACM, reducing the number
f synapses induced to control levels (Figure 3D). Inter-
stingly, despite the lack of double-labeled synaptic
uncta in RGCs cultured with TSP2-depleted ACM,
here was still a significant increase in the number of
ingle-labeled puncta containing nonoverlapping syn-
ptotagmin or PSD-95 immunoreactivity (Figure 3E).
hese findings demonstrate that TSP2 is necessary for
strocytes to enhance synaptogenesis and suggest thatTSP2 may normally enhance synaptogenesis by inducing
Thrombospondins Promote CNS Synaptogenesis
425Figure 3. TSP2 Is Necessary for the Increase in Synapse Number Induced by ACM
(A) Immunostaining of RGCs for colocalization of presynaptic synaptotagmin (red) and postsynaptic PSD-95 (green) shows few synaptic
puncta in the absence of astrocytes (Control) but many in the presence of recombinant TSP2 (rTSP2).
(B) Quantification of the increase in synaptic puncta with rTSP2 indicates that rTSP2 is sufficient to increase the number of structural
synapses. Asterisks correspond to p < 0.001 compared to control.
(C) Immunodepletion with a TSP2-specific antibody depletes from ACM.
(D) Depletion of TSP2 from ACM reduces synapse-promoting activity to control levels. Asterisks correspond to p < 0.05 compared to control.
(E) Mock-depleted ACM retains full synapse-promoting activity (synaptotagmin, red; PSD-95, green), while TSP2-depleted ACM is depleted
of synapse-promoting activity. TSP2-depleted ACM promotes an increase in the number of pre- and postsynaptic labeling on neurons, but
the puncta are no longer colocalized. Error bars are the mean ± SEM. Scale bars are 30 m.or maintaining the alignment and/or adherence of pre-
and postsynaptic specializations.
ACM and TSP1 Induce Formation of Postsynaptically
Silent Synapses
Despite their potent effects on increasing structural
synapse number, neither ACM, TSP1, nor TSP2increased synaptic activity as measured by whole-cell
patch clamp recording (Figure 4A; Supplemental Figure
S4). In contrast, astrocyte feeding layers significantly
increased the frequency of synaptic events (Figure 4A).
We next investigated whether the TSP1- and ACM-
induced synapses were presynaptically active by
measuring vesicular release using an antibody to the
Cell
426Figure 4. TSP1-Induced Synapses Are Presynaptically Active but Postsynaptically Silent
(A) Measurement of spontaneous mEPSCs shows that neither ACM nor TSP1 increase event frequency above control levels, in contrast to a
feeding layer of astrocytes (Astros).
(B) RGCs treated with ACM, TSP1, and astrocyte feeding layer (Astros) all have significantly more presynaptic uptake of an anti-synaptotagmin
luminal domain antibody than neurons cultured alone (Control), indicating that ACM- and TSP1-induced synapses are presynaptically active.
(C) Whole-cell L-glutamate responses indicate that ACM and TSP1 do not increase postsynaptic responses to glutamate above control levels,
in contrast to astrocyte feeding layers (Astros). Inset depicts the postsynaptic glutamate response in an RGC grown with an astrocyte feeding
layer, indicating that it is mediated by non-NMDA receptors.
(D) Measurement of cumulative amplitude distributions reveals that neither ACM nor TSP1 increase mEPSC amplitudes above control, in
contrast to astrocyte feeding layer. This indicates that few functional glutamate receptors are present at synaptic sites. These results indicate
that TSP1 and ACM do not increase postsynaptic glutamate receptor expression or function. Asterisks in all panels correspond to p < 0.05
compared to control. Error bars are the mean ± SEM.luminal domain of the vesicular protein synaptotagmin o
rand the styryl dye FM2-10, both of which are taken up
in an activity-dependent manner when synaptic vesi- u
mcles recycle (Kraszewski et al., 1995). Double immu-
nolabeling indicates that most presynaptic puncta e
doverlapped with PSD-95 postsynaptic puncta in all
conditions. TSP1, ACM, and an astrocyte feeding layer R
tall increased the number of sites of spontaneous syn-
aptic vesicular recycling in RGCs to a similar extent a
T(Figure 4B; Supplemental Figure S5). This was not due
to a general increase in synaptic proteins (Supplemen- i
ttal Figure S2; Ullian et al., 2001). In addition, the fold
increase in the number of presynaptically active puncta s
per cell in all three conditions was similar to the fold
increase in the number of structural synapses mea- A
asured by immunostaining and EM, consistent with the
sites of vesicular recycling corresponding to synaptic t
psites. These results indicate that the majority of syn-
apses induced by astrocyte feeding layers, ACM, and F
aTSP1 are presynaptically active.
To assess postsynaptic function, we first examined a
cwhole-cell responses of RGCs cultured in the presencef TSP1 or ACM to applied glutamate and found that
esponses were not increased above control levels (Fig-
re 4C). To specifically look at synaptic receptors, we
easured the amplitudes of spontaneous miniature
vents (mEPSCs). The cumulative mEPSC amplitude
istribution shows that the synaptic events recorded in
GCs cultured with either TSP1 or ACM are smaller
han those induced by a feeding layer of astrocytes and
re about 5-fold less sensitive to glutamate (Figure 4D).
his suggests that there is a second signal generated
n the presence of astrocyte feeding layers that func-
ions by either recruiting glutamate receptors to the
ynapse or by activating them.
Despite the lack of functional AMPA receptors at
CM- and TSP1-induced synapses, TSP1-induced syn-
pses exhibited normal postsynaptic densities by EM
hat are strongly immunoreactive for the postsynaptic
roteins PSD-95, SAP-102, and Homer (Supplemental
igure S6). Thus, whereas astrocyte-induced synapses
re fully functional, both ACM- and TSP1-induced syn-
pses are presynaptically active but are postsynapti-
ally silent, containing fewer functional AMPARs. These
Thrombospondins Promote CNS Synaptogenesis
427similar properties of ACM- and TSP1-induced synapses
provide further evidence that TSPs are a component of
the synaptogenic activity of ACM.
RGC synaptic responses in vitro and in vivo are
largely AMPA receptor mediated, with a small NMDA
receptor-mediated component in the absence of Mg2+
(Chen and Diamond, 2002; Ullian et al., 2004a). In order
to determine whether TSP1-induced synapses release
glutamate that can activate postsynaptic NMDA recep-
tors, we analyzed the evoked responses of RGCs
treated with TSP1 or astrocyte feeding layers in the
presence and absence of Mg2+. In contrast to astrocyte
feeding layer-induced synapses, RGCs treated with
TSP1 exhibited no AMPA component to the evoked re-
sponse when currents were elicited in the presence of
Mg2+, but a small NMDA component was detectable in
the absence of Mg2+ (Supplemental Figure S4). Thus,
despite the lack of postsynaptic AMPA receptors, the
TSP-induced synapses are functional in that they re-
lease glutamate and exhibit small NMDAR-mediated
components of the evoked response.
TSPs Colocalize with Synaptic Markers and Are
Expressed by Astrocytes In Vivo
To determine whether TSP1 and TSP2 are expressed in
the developing brain, we used antiserum against TSP1
to immunostain postnatal brain, the age at which the
bulk of synaptogenesis occurs. It is not clear whether
this antiserum also recognizes the highly related isoform
TSP2, so we refer to the immunoreactivity as TSP1/2.
TSP1/2 immunoreactivity was observed throughout the
postnatal day 8 (P8) cortex, superior colliculus, and ret-
ina, and appears diffuse and widespread, as expected
for a matrix molecule secreted by astrocytes (Figure 5
and data not shown). Interestingly, TSP1/2 immunore-
activity was also seen in discrete puncta that coloca-
lized with the synaptic marker synaptotagmin in both
cortex (Figure 5A) and superior colliculus (Figure 5B).
We also found extensive colocalization of TSP1/2 with
ezrin (Figure 5C), a marker of the fine astrocyte pro-
cesses that ensheathe synapses in the postnatal CNS
(Derouiche and Frotscher, 2001). Interestingly, TSP1/2
immunoreactivity largely disappeared in these brain re-
gions by postnatal day 21 (P21; Figure 5D), suggesting
that TSP1 and TSP2 serve a transient function and are
not required for maintenance of synapses in the adult.
In order to more directly determine whether TSP1 and
TSP2 proteins are present in the postnatal and adult
rat brain, we used TSP1- and TSP2-specific antibodies,
which work well for Western blotting but not immuno-
staining, to look at protein expression. Both TSP1 and
TSP2 proteins were detected in extracts prepared from
rat P5 cortex (Figure 5E) and whole brain (data not
shown). As we observed for the immunoreactivity, both
TSP1 and TSP2 protein levels were very low or absent
in adult brain. To further examine which TSPs are pre-
sent in astrocytes in postnatal brain, we performed RT-
PCR on mRNA isolated from highly purified, acutely
isolated astrocytes from P5 rat cortex. Both TSP1 and
TSP2 mRNAs were detected (data not shown). Taken
together, these results show that both TSP1 and TSP2
are present in the developing brain, where they are
highly localized to astrocytes, and are downregulated
in adult brain.Developing Brains Deficient in TSP1 and TSP2
Form Fewer Synapses
In order to determine if TSP1 and TSP2 play a role in
CNS synapse formation in vivo, we examined synapse
number in brain cryosections prepared from wild-type
(wt) mice and mice lacking TSP1, TSP2, or both (Agah
et al., 2002) by immunostaining with antibodies to syn-
aptic markers followed by confocal imaging (Figure 6A).
No decrease in synapse number was detected in TSP1-
or TSP2-deficient mice. However, in the TSP1/2 double
null cerebral cortex, there was a 40% decrease in syn-
aptic puncta at P8 as quantified by SV2 immunoreactiv-
ity (Figure 6B). Even by P21, a time when synapse
number has normally plateaued, there was still a 25%
decrease in synaptic puncta compared to wt controls
(Figure 6C). A similar decrease in synapse number was
observed in TSP1/2 double null brain sections from the
superior colliculus (data not shown). There was sub-
stantial variability between brain regions and mice, with
decreases in cortical synapse number that ranged as
high as 50% in some cases. Similar results were ob-
tained using antibodies to other synaptic proteins in-
cluding Bassoon and PSD-95, indicating that the de-
creased puncta likely corresponded to a decrease in
synapse number rather than simply a decrease in the
synaptic localization of a particular protein.
To verify that these puncta correspond to synapses
as defined by colocalization of pre- and postsynaptic
proteins, we double labeled cryosections of P21 wt and
TSP1/2 double null brains using antibodies to the pre-
synaptic protein Bassoon (BSN) and the postsynaptic
protein SAP-102 (Lim et al., 2002; Figure 7A). We used
novel trichloroacetic acid fixation conditions that al-
lowed both pre- and postsynaptic markers to be simul-
taneously immunostained. We saw a similar 31%
decrease in the number of colocalized pre- and post-
synaptic puncta in TSP1/2-deficient brains compared
to wt (Figure 7B). Similar to our cell culture results, we
did not see an overall decrease in the levels of synaptic
proteins in TSP1/2 double null brains compared to wt
(Supplemental Figure S7).
To determine whether the effect of TSP1/2 deficiency
on synapse number was direct and not secondary to
effects on cell survival, proliferation, or migration, we
counted the number of DAPI-stained nuclei per section
in P21 cortex. We found no significant difference in the
number of DAPI nuclei between wt and TSP1/2 double
null brains (85 ± ten nuclei per area wt; 97 ± ten nuclei
per area TSP1/2 double null, p = 0.4). In addition, there
was no obvious difference in the morphology of cortical
structures or layers. To determine whether the effect of
deleting TSP1/2 on synapse number was due to de-
fects in dendritic arborization, we quantified the density
of dendritic fields in synaptic areas of the cortex. We
found no significant morphological difference in den-
dritic structures or dendritic arbor density between wt
and TSP1/2 double null brains at P21 or P8 (Figures
7C and 7D). These data, together with the persistent
decrease in synapse number at the nearly adult age
of P21, provide evidence that the decrease in synapse
number in TSP1/2-deficient mice cannot be explained
by a decrease in cell number or dendritic number or
length but rather is due to a specific inability to form or
maintain a normal number of synapses. Taken together,
Cell
428Figure 5. TSP1/2 Immunoreactivity Is Localized to Astrocyte Processes at Many Synapses throughout the Developing Brain
(A and B) Confocal images of immunolabeled rat P8 brain sections reveal TSP1/2 throughout the cortex and superior colliculus (SC). TSP1/2
immunoreactivity is located at synaptic sites as indicated by double labeling for TSP1/2 and synaptotagmin (SYN).
(C) Immunolabeling of cortex for TSP1/2 and the fine glial process marker ezrin. Merged images indicate that TSP1/2 is located to fine
astrocyte processes, many of which surround synapses.
(D) Immunostaining of TSP1/2 in P8 and P21 cortex. TSP1/2 immunoreactivity is undetectable by P21.
(E) Western blot analysis of P5 rat cortical lysates shows that both TSP1 and TSP2 proteins are present in postnatal cortex and are downregu-
lated in adult cortex. Scale bars are 10 m (A and B), 2 m (C), and 100 m (D).these findings provide evidence that TSP1 and TSP2 t
are astrocyte-derived proteins that help to promote T
CNS synaptogenesis in vitro and in vivo. t
s
dDiscussion
t
TTSP1 and TSP2 Are Astrocyte-Secreted Proteins
athat Promote CNS Synaptogenesis
sThe results reported here support several conclusions.
First, we show that nonneuronal proteins exist that can drigger CNS synaptogenesis and identify TSP1 and
SP2 as astrocyte-secreted proteins that are sufficient
o induce the formation of ultrastructurally normal CNS
ynapses. Second, although TSPs induce postsynaptic
ifferentiation as indicated by EM analysis and induc-
ion of postsynaptic protein clustering, we find that
SP1- and TSP2-induced synapses are presynaptically
ctive but postsynaptically silent, lacking AMPAR re-
ponsiveness. Therefore, an unidentified astrocyte-
erived signal is necessary for full postsynaptic func-
Thrombospondins Promote CNS Synaptogenesis
429Figure 6. Quantification of Synapse Number in TSP1/2 Double Null
Brain
(A) Confocal sections of P21 rat cortex immunostained for presyn-
aptic marker SV2 in wt and TSP1/2 double null brains. Scale bar is
10 m.
(B) Quantification of synaptic puncta in matched cortical fields from
P8 wt and TSP1/2 double null brains. A significant reduction in syn-
apse number in TSP1/2 double null brains was found (p = 0.0046).
(C) Quantification of synaptic puncta in matched cortical fields from
P21 wt and TSP1/2 double null brain. A significant reduction in
synapse number in TSP1/2 double null brains was found (p =
0.0169). Error bars are the mean ± SEM.tion in vitro. Third, TSP2 is necessary for the ability of
astrocytes to induce the formation of structural syn-
apses between RGCs in vitro. Fourth, TSP1 and TSP2
are expressed in the postnatal but not adult CNS where
they are broadly localized in astrocytes and synapses,
as expected for an astrocyte-secreted matrix molecule.
Finally, mice lacking both TSP1 and TSP2 have a sub-
stantially reduced number of synapses in many CNS
regions, indicating that these TSPs help to promote
normal CNS synaptogenesis in vivo. It is possible that
the degree of synapse loss might be substantially
larger in the absence of additional TSP family mem-
bers, given that both TSP3 and TSP4 may be expressed
in adult brain (Arber and Caroni, 1995; Iruela-Arispe et
al., 1993).TSP-Induced Synapses Are Postsynaptically Silent
An important implication from this study is that astro-
cyte-induced CNS synapse formation in culture requires
at least two steps that are mechanistically distinct. First,
TSPs induce the formation of ultrastructurally normal
synapses bearing pre- and postsynaptic specializa-
tions that are presynaptically active but postsynapti-
cally silent. Second, an unidentified astrocyte signal in-
duces postsynaptic function by inserting functional
AMPARs into postsynaptic sites. In preliminary experi-
ments, we have found that feeding layers of astrocytes
but not ACM or TSP induce clustered AMPA receptor
immunoreactivity at postsynaptic sites on RGCs. This
is reminiscent of the two-step model for activation of
silent synapses in the developing brain thought to be
important for synapse refinement and circuit modifica-
tion wherein silent structural synapses are initially
formed and some become postsynaptically functional
in a second step involving an activity-dependent LTP
mechanism (Isaac et al., 1997; Malenka and Nicoll,
1997). Our findings provide evidence that astrocytes
may be actively involved in both of these steps.
How Do TSPs Induce Synaptogenesis?
Many neuronal molecules work in concert to build a
CNS synapse. The transmembrane neuronal proteins
neuroligin and neurexin constitute an important part of
the intrinsic synaptic machinery (reviewed in Scheiffele
[2003]; Chih et al. [2005]; Graf et al. [2004]). They work
in concert with a number of soluble neuronal proteins
that specifically promote either post- or presynaptic
differentiation including ephrins, Narp/NP2, Wnt7A, and
FGF22 (Scheiffele, 2003; Umemori et al., 2004), as well
as with soluble astrocyte-derived signals such as cho-
lesterol (Mauch et al., 2001) and an as yet unidentified
signal reported here, that further help to promote pre-
and postsynaptic function. We have shown that TSP1
and TSP2 are necessary and sufficient to induce syn-
apses that exhibit both pre- and postsynaptic differen-
tiation.
How do TSP1 and TSP2 induce synaptogenesis? The
increase in synapse number by TSPs could be caused
by an increase in formation of new synapses, stabiliza-
tion of existing synapses, or both. Because RGC syn-
apses are rapidly lost when astrocytes are removed,
the simplest possibility is that TSPs act by stabilization.
In the developing brain, initially formed synapses might
be immature and highly plastic, with TSPs serving to
increase synapse number by locking synapses into
place. The well-known ability of TSPs to regulate cell
adhesion fits well with this possibility. In addition, RGCs
cultured in TSP2-depleted ACM failed to form synapses
but exhibited a large number of pre- and postsynaptic
specializations that were not juxtaposed. This could be
a result of initial synapse formation followed by desta-
bilization and is reminiscent of the misalignment phe-
notype that occurs at the neuromuscular junction in the
absence of laminin α4, where synaptic specializations
are present but not precisely apposed (Patton et al.,
2001).
We do not know yet whether TSPs act at the cell
body or at axon terminals. However, the several day
Cell
430Figure 7. Quantification of Colocalization of Pre- and Postsynaptic Puncta in TSP1/2 Double Null Brain
(A) Wt and TSP1/2 double null P21 cortex immunolabeled for presynaptic Bassoon (BSN) and postsynaptic SAP102. Fewer synaptic puncta
containing both pre- and postsynaptic markers are present in TSP1/2 double null brains compared to wt. Scale bar is 6 m.
(B) Quantification of colocalization of pre- and postsynaptic markers in brain sections from wt and TSP1/2 P21 double null brains. A 31%
reduction in the number of colocalized synaptic puncta was observed in TSP1/2 double null brains compared to wt brains (p = 0.026).
(C) MAP2 immunostaining in P21 wt and TSP1/2 double null brain. Scale bar is 120 m.
(D) Quantification of dendritic area shows no difference in dendritic fields (p > 0.05). Error bars are the mean ± SEM.period required to see the effect of TSPs strongly sug- g
tgests the possibility that they may act at least in part
by inducing neurons to alter expression of proteins that s
sparticipate in synaptogenesis. A number of known TSP
receptors are concentrated at CNS synapses, including
dRGC synapses (C. Eroglu and B.A.B., unpublished
data). Known TSP receptors include the CD47 integrin- b
massociated protein (CD47/IAP), a variety of integrins,
and the low-density lipoprotein receptor-related protein p
fLRP1. By binding to one or more of these receptors,
TSPs might activate downstream pre- and/or postsyn- i
aaptic signaling cascades that induce the formation of
synaptic adhesions. Alternatively or in addition, TSPs e
bare capable of functioning as deadhesive proteins un-
der certain circumstances (Murphy-Ullrich, 2001) and t
dthus might switch growth cones from a neurite out-rowth mode into a synaptogenic mode by allowing
hem to deadhere from outgrowth promoting sub-
trates. Identification of the relevant TSP receptor
hould help to distinguish between these possibilities.
An important question for future research will be to
etermine whether TSP promotes synapse formation
y acting instructively or permissively. An instructive
odel would imply that local concentrations of TSPs at
articular synapses help determine which synapses are
ormed and which are not; a permissive model would
mply that the presence of TSP is necessary for syn-
pse formation or maintenance but that other signaling
vents control exactly which synapses are formed. The
road distribution of TSP1/2 localization, the possibility
hat it acts transcriptionally, and its specific window of
evelopmental timing favor a permissive model.
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for Understanding Normal CNS
Development and Disease
The identification of TSP1 and TSP2 as CNS synapto-
genic proteins has important implications. The abun-
dance of TSPs in vivo is dynamically regulated during
development, being low in late embryonic brain, higher
in postnatal brain, and low or absent in the adult brain
(Iruela-Arispe et al., 1993). The CNS levels of TSP1 and
TSP2 thus correlate closely with the time interval when
the rodent brain normally forms synapses during the
first 3 postnatal weeks, and release of astrocyte-
derived TSPs could explain the close temporal and
spatial correlation of astrocyte development with syn-
apse development (Ullian et al., 2001). Moreover, the
downregulation of TSP1/2 levels in adult brain corre-
lates with the relatively poor ability of the adult CNS to
form new synapses. These results therefore suggest
the hypothesis that TSP1/2 levels act as a permissive
switch that helps to control the timing of CNS synapto-
genesis and raise the question of whether administra-
tion of exogenous TSP1/2 would restore the synapto-
genic capacity of normal adult brain or enhance the
regeneration of new synapses in injured adult brain.
Although TSP1 and TSP2 levels are normally low in
the adult brain, reactive astrocytes and activated
microglia express these proteins (Lin et al., 2003; Moller
et al., 1996). Reemergence of TSPs in reactive astro-
cytes could thus help to explain the formation of un-
wanted, extra synapses that result in epilepsy at
astrocytic scars as well as help to explain the tendency
of axotomized axons to synaptically differentiate and
fail to regenerate when they contact reactive astrocytes
(Liuzzi and Lasek, 1987). If so, drugs that agonize or
antagonize TSPs may help to promote synaptic plastic-
ity and repair in many CNS diseases.
In conclusion, we have shown that TSPs are astro-
cyte-derived proteins that help to promote CNS synap-
togenesis and that they work in concert with other, as
yet unidentified, astrocyte-derived signals to produce
functional synapses. Our findings, together with other
recent work (reviewed in Ullian et al. [2004b]), increas-
ingly suggest that astrocytes should no longer be
viewed primarily as passive support cells but rather as
cells that actively help to control the formation and
function of synapses in developing and adult or-
ganisms.
Experimental Procedures
Purification and Culture of RGCs
Step-by-step protocols for all procedures are available on request
to barres@stanford.edu. RGCs were purified by sequential immu-
nopanning to greater than 99.5% purity from P5 Sprague-Dawley
rats (Simonsen Labs, Gilroy, CA) and cultured in serum-free me-
dium containing BDNF, CNTF, and forskolin on laminin-coated cov-
erslips, as previously described (Barres et al., 1988; Meyer-Franke
et al., 1995; Ullian et al., 2001).
Purified human platelet TSP1 was obtained from either Sigma or
Haematologic Technologies. Recombinant TSP2 was purified from
serum-free medium conditioned by baculovirus-infected insect
cells expressing mouse TSP2. Since purified TSP1 is readily avail-
able, we used this as the source of TSP in our experiments unless
otherwise noted. TSPs were used at a concentration of 5 µg/ml(w10 nM). Biglycan, CSPG A, CSPG C, decorin, and osteopontin
were from Sigma; agrin was from R&D Systems; collagen IV was
from BD Biosciences; fibronectin, osteonectin, and vitronectin
were from Haemtech; and tenascin C was a generous gift from M.
Schachner. All matrix molecules were used at a concentration of 5
µg/ml, except collagen IV, which was used at 10 µg/ml, and the
CSPGs, which were used at 1 µg/ml to avoid overfasciculation.
GDNF (10 ng/ml), TNFα (10 ng/ml), TGFβ1(10 ng/ml), bFGF (10 ng/
ml), and HGF (50 ng/ml) were from Preprotech; IL-6 (10 ng/ml) was
from Sigma; and pleiotrophin (50 ng/ml) was from R&D Systems.
RCGs were cultured for 3–4 days to allow robust process out-
growth and then cultured with astrocyte feeding layers, ACM or
factors for an additional 6 days. TTX and Picrotoxin were obtained
from RBI. All other reagents were obtained from Sigma. Cholesterol
was used at a final concentration of 10 g/ml.
Preparation of Astrocytes and ACM
Cortical astrocytes were prepared as described (McCarthy and de
Vellis, 1980). Astrocytes were then plated onto 24-well inserts (Fal-
con, 1.0 µm) or 10 cm tissue culture dishes. For preparation of
ACM, confluent cultures of astrocytes in 10 cm dishes were
washed three times in PBS and fed with 10 ml RGC medium (with-
out CNTF, BDNF, or forskolin). ACM was harvested after 4–6 days
of conditioning, filtered through a 0.2 µm syringe filter, and concen-
trated ten times through a 5 kDa molecular weight cutoff centrifuge
concentrator (Millipore), unless otherwise indicated. ACM was used
at a final concentration of 5× unless otherwise indicated. RCGs
were cultured for 4 days to allow robust process outgrowth and
then cultured with ACM or an astrocyte feeding layer for an addi-
tional 6 days.
Electrophysiology
Membrane currents were recorded by whole-cell patch clamping
at room temperature (18°C–22°C) at a holding potential of −70 mV
unless otherwise specified. Patch pipettes (3–10 M) were pulled
from borosilicate capillary glass (WPI). For recordings of synaptic
or whole-cell glutamate currents, the bath solution contained (in
mM) 120 NaCl, 3 CaCl2, 2 MgCl2, 5 KCl, and 10 HEPES (pH 7.3).
For recording in Mg2+-free conditions, the external bath solution
contained (in mM) 140 NaCl, 3.5 KCl, 10 HEPES, 20 glucose, 3
CaCl2, and 20 M glycine (pH 7.3). TTX (2 M) and bicuculine (10
M) were added for spontaneous miniature event recordings. The
internal solution contained (in mM) 100 K-gluconate, 10 KCl, 10
EGTA (Ca2+ buffered to 10−6 molar), and 10 HEPES (pH 7.3). For
recordings of autaptic currents, the internal solution contained (in
mM) 122.5 K-gluconate, 8 NaCl, 10 HEPES, 0.2 EGTA, 2 Mg-ATP,
0.3 Na-GTP, 20 K2-creatine phosphate, and phosphocreatine ki-
nase (50 U/ml). Currents were recorded using pClamp software for
Windows (Axon Instruments, Foster City, CA). Glutamate (250 mM)
and CNQX (10 M) were rapidly applied by a quartz microtube ar-
ray (Superfusion System, ALA Scientific Instruments, New York).
Mini excitatory postsynaptic currents (mEPSCs) were analyzed
using Mini Analysis Program (SynaptoSoft, Decatur, GA) and plot-
ted using SigmaPlot (SPSS, Chicago, IL) or Origin (Microcal, North-
ampton, MA).
Synaptic Assays
For synapse quantification, cultures were fixed for 7 min in 4%
paraformaldehyde (PFA), washed three times in phosphate-buf-
fered saline (PBS), and blocked in 100 µl of a blocking buffer con-
taining 0.1% Triton X-100 for 30 min. After blocking, cover slips
were washed three times in PBS, and 100 µL of primary antibody
solution was added to each cover slip, consisting of rabbit anti-
synaptotagmin (cytosolic domain, Synaptic Systems) and mouse
anti-PSD-95 (6G6-1C9 clone, Affinity Bio Reagents) or rabbit anti-
GluR2/3 (Chemicon) diluted 1:500 in antibody buffer. Coverslips
were incubated overnight at 4°C, washed three times in PBS, and
incubated with 100 µl of Alexa-594 conjugated goat anti-rabbit and
Alexa-488 conjugated goat anti-mouse (Molecular Probes) diluted
1:1000 in antibody buffer. Following incubation for 2 hr, coverslips
were washed five times in PBS and mounted in Vectashield mount-
ing medium with DAPI (Vector Laboratories Inc) on glass slides
Cell
432(VWR Scientific). For presynaptic activity assay, rabbit synaptotag- t
tmin antiserum was generated by immunization with a peptide cor-
responding to the N-terminal luminal portion of synaptotagmin. o
bThis serum was added at 1:500 to live cultures and incubated for 6
hr. Cells were then washed three times in DPSB, fixed, and stained P
fas above, except for the omission of synaptotagmin antibody from
the primary antibody solution. Secondary-only controls were rou- 8
Stinely performed and revealed no significant background staining.
Mounted coverslips were imaged using Nikon Diaphot and Ec- 1
dclipse epifluorescence microscopes (Nikon). Conditions were de-
termined positive and warranted further analysis if a difference in n
acolocalized puncta could be detected by eye, an increase of ap-
proximately 20%, in both duplicate coverslips. Healthy cells that S
awere at least two cell diameters from their nearest neighbor were
identified and selected at random by eye using DAPI fluorescence. P
Eight bit digital images of the fluorescence emission at both 594
nm and 488 nm were recorded for each selected cell using a cooled E
monochrome CCD camera and SPOT image capture software (Di- C
agnostic Instruments, Inc). These manipulations were performed s
automatically using the custom software package SpotRemover I
(Barry Wark, source code and/or binaries available upon request to w
bwark@stanford.edu/barrywark@mac.com) on Macintosh OS X. c
Colocalized puncta were identified using a custom-written plug-in f
(Barry Wark, licensed under the GPL [http://www.gnu.org/copyleft/ c
gpl.html]) for the NIH image processing package ImageJ v1.24 and d
greater (available at http://rsb.info.nih.gov/ij/). Full documentation b
of the puncta-counting algorithm is available in the “Puncta Ana- o
lyzer” plug-in’s source code. We verified that this analysis gener-
ates counts that are similar to the numbers we obtain counting C
by eye. I
S
aImmunodepletion and Western Analysis
ACM (10×) was incubated with 20 µl goat anti-ApoE (a generous b
sgift from Karl Weisgraber, UCSF) or 10 µl rabbit anti-TSP2 serum
(Tooney et al., 1998) overnight at 4°C. Primary antibodies with k
qbound proteins were removed from ACM by incubation with 20 µl
protein G or protein A-Sepharose beads (Pierce), respectively, for s
e2 hr at 4°C followed by centrifugation to separate the supernatant,
and a sample was saved for Western blotting before addition to a
sRGC cultures.
For preparation of P5 and adult rat or P8 mouse cortical lysates, b
pcortices were homogenized in 20 volumes w/v lysis buffer (25 mM
Tris 7.4, 150 mM NaCl, Complete Protease Inhibitor Cocktail b
1[Roche]). After homogenization, sodium deoxycholate was added
to a final concentration of 1%, and homogenate was solublized at p
o4°C for 30 min with rocking. Lysates were cleared by centrifugation
at 16 × g for 20 min at 4°C, and 30 g of each lysate was used for t
sWestern analysis. For preparation of RGC lysates, RGCs cultured
in 6-well dishes were lysed with M-PER Mammalian Protein Extrac- e
8tion Reagent (Pierce), incubated at 4°C for 30 min, and cleared by
centrifugation at 16 × g for 10 min at 4°C. Each lysate was loaded o
at 5 g per lane.
Proteins in ACM or lysates were resolved by SDS-PAGE and
transferred onto PVDF (Millipore). Membranes were incubated in S
blocking buffer (PBS containing 0.1% Tween-20 and 5% nonfat S
milk) for 30 min at room temperature, followed by incubation for 1 m
hr or overnight at 4°C in blocking buffer containing either rabbit h
anti-ApoE (1:500, a generous gift from Karl Weisgraber, UCSF),
mouse anti-TSP1 (1:250, BD Transduction), mouse anti-TSP2
(1:250, BD Transduction), rabbit anti-synaptotagmin (1:1000, Syn- A
aptic Systems), mouse anti-PSD-95 (1:000, clone 6G6-1C9, Affinity
BioReagents), mouse anti-β-actin (1:2000, AC-15, Sigma), mouse W
anti-synapsin (1:5000, clone 46.1, Synaptic Systems), rabbit anti- m
SAP102 (1:1000, J.W.H.), or rabbit anti-Bassoon (1:200, Synaptic a
Systems). Immunoreactive proteins were detected using HRP-con- w
jugated anti-rabbit or anti-mouse IgG (1:10,000; Jackson Immuno- w
research) and visualized with a chemiluminescent substrate for A
HRP (SuperSignal West Pico; Pierce Chemicals). Protein levels t
were quantified using ImageJ (NIH). K
e
HImmunohistochemistry
Brains were immersion fixed in 4% PFA overnight or, for double I
Jlabels of synaptic puncta, brains were immersion fixed in 10%richloroacetic acid for 1 hr at RT (Hayashi et al., 1999). Brains were
hen washed in 30 mM glycine PBS and sunk in 30% sucrose PBS
vernight at 4°C. Brain sections were dried 30 min at 37°C followed
y application of blocking buffer. Slides were washed 3 × 5 min in
BS. Primary antibodies used were diluted into antibody buffer as
ollows: TSP1 (P10, mouse monoclonal, Immunotech, 1:200 or Ab
, Neomarkers, rabbit, 1:200), synaptotagmin (rabbit polyclonal,
ynaptic Systems, 1:500), ezrin (monoclonal 3C12, Neomarkers,
:200), SV2 (hybridoma supernatant, Developmental Studies Hybri-
oma Bank, 1:30), Bassoon (Stressgen, 1:400), PSD-95 (monoclo-
al 6G6-1C9, Affinity Bioreagents, 1:250), SAP-102 (J.W.H.; 1:200),
nd incubated overnight at 4°C followed by three washes in PBS.
econdary Alexa-conjugated antibodies (Molecular Probes) were
dded at 1:1000 for 2 hr at RT. Slides were washed three times in
BS and mounted in Vectashield plus DAPI.
lectron Microscopy
ells were prepared for EM using glutaraldehyde as previously de-
cribed (Ullian et al., 2001) and viewed with a Philips Electronic
nstruments CM-12 transmission electron microscope. Synapses
ere counted by eye under the electron microscope by finding a
ell body and dendrites and counting all synapses within a circular
ield of radius approximately one cell body diameter. Docked vesi-
les were identified as those within 50 nM from the presynaptic
ensity. Postsynaptic density thickness and length were measured
y drawing a line along the visible portion of the density thickness
r length and automatically measuring line distance using ImageJ.
onfocal Analysis of Synapse Number
mages of immunostained brains were collected on a Leica SPS
P2 AOBS confocal microscope. Optical sections were line
veraged and collected at 0.28 M intervals. Gain, threshold, and
lack levels were individually adjusted per section to cover the
ame range of pixel values or were set for the wt sections and
ept constant for all sections. Stacks of 20 optical sections were
uantified for synapse number by projecting a series of five optical
ections, a number empirically determined to optically section the
ntirety of most synaptic puncta, and counting the number of syn-
pses in each projection volume. For double-label experiments,
ingle scans were taken of equivalent cortical areas in wt or KO
rains. Synapses were automatically counted using the ImageJ
uncta analyzer program and the accuracy of the counts confirmed
y counting by hand. n = 6 hemispheres for P8 wt and KO, and n =
0 hemispheres and for P21 wt and KO. On average, three stacks
er hemisphere were obtained, yielding a total of 18 stacks (72
ptical sections) for synaptic puncta analysis for P8 brains and a
otal of 30 stacks (120 optical sections) for synaptic puncta analy-
is for P21 brains. For double-label experiments, three brains from
ach condition (KO and wt) were sectioned and scanned. A total of
0 scans for wt and 80 scans for KO were done, and the number
f colocalized puncta was determined by using ImageJ.
upplemental Data
upplemental Data include seven figures, one table, and Supple-
ental References and can be found with this article online at
ttp://www.cell.com/cgi/content/full/120/3/421/DC1/.
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